streptavidin

Streptavidin is a protein tetramer purified from bacteria with a very high affinity for biotin and is commonly used for the purification or detection of various biomolecules. Streptavidin is immunologically active, inhibiting IL-2 synthesis and CD25 expression in T cells.

DPPE-PEG550 serves as a PEG lipid functional terminal group used for synthesizing liposomes (LPs) to design conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) are capable of further coupling with other biomolecules through biotin modification and carboxyl terminals. Functionalized nanoparticles can target specific cell proteins for labeling purposes. Using streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind with biotinylated antibodies on cell surface receptors, enabling applications in fluorescence-based imaging and sensing.

DPPE-PEG750 is a PEG lipid functional end group used for synthesizing liposomes (LPs) and designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) modified with biotin and carboxylic ends can couple with other biomolecules. These functionalized nanoparticles are useful for targeting specific cell proteins. Using streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, facilitating fluorescence-based imaging and sensing applications.

DPPE-PEG1000 is a PEG lipid functional end group used for synthesizing liposomes (LPs) and is instrumental in designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs), featuring biotin modification and carboxyl terminals, can further couple with other biomolecules. These functionalized nanoparticles are useful for the targeted labeling of specific cell proteins. By employing streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling applications in fluorescence-based imaging and sensing.

DPPE-PEG3000 is a PEG lipid functional end group used for synthesizing liposomes (LPs) and designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) modified with biotin and having a carboxylate end can further couple with other biomolecules. The functionalized nanoparticles are applicable for targeted labeling of specific cell proteins. Using streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can interact with biotinylated antibodies on cell surface receptors, facilitating fluorescence-based imaging and sensing applications.

DPPE-PEG5000 is a PEG lipid functional terminal group utilized for synthesizing liposomes (LPs) and designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) with biotin modification and carboxyl ends can further couple with other biomolecules. These functionalized nanoparticles target specific cellular proteins for labeling. Using streptavidin as a linker, the biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling applications in fluorescence-based imaging and sensing.

18:0 mPEG350 PE (ammonium) is a PEG lipid with functional terminal groups used in the synthesis of liposomes (LPs) for designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs), featuring biotin modification and a carboxyl terminus, enable further coupling with other biomolecules. These functionalized nanoparticles can target specific cell protein labeling. Using streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind with biotinylated antibodies on cell surface receptors, providing practical applications in fluorescence-based imaging and sensing.

18:0 mPEG550 PE (ammonium) is designed for synthesizing liposomes (LPs) with PEG lipid functional end groups, facilitating the creation of conjugated polymer nanoparticles. The liposomal nanoparticles (LNPs), modified with biotin and carboxyl ends, can further couple with various biomolecules. These functionalized nanoparticles are applicable in targeting specific cellular proteins. By utilizing streptavidin as a linker, the biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling applications in fluorescence-based imaging and sensing.

18:0 mPEG750 PE (ammonium) serves as a PEG lipid functional terminal for synthesizing liposomes (LPs) in the design of conjugated polymer nanoparticles. Liposomal nanoparticles (LNPs) featuring biotin modification and carboxyl terminals can couple with other biomolecules. These functionalized nanoparticles are applicable for targeting specific cellular proteins. Utilizing streptavidin as a linker, the biotinylated PEG lipid-conjugated polymer nanoparticles can bind with biotinylated antibodies on cell surface receptors, enabling fluorescence-based imaging and sensing applications.

18:0 mPEG1000 PE (ammonium) is a PEG-lipid functional end group utilized in the synthesis of liposomes (LPs) and in designing conjugated polymer nanoparticles. These liposome nanoparticles (LNPs), modified with biotin and carboxyl ends, can further couple with other biomolecules. Functionalized nanoparticles are applicable for targeted labeling of specific cellular proteins. With streptavidin as a linker, the biotinylated PEG-lipid conjugated polymer nanoparticles bind to biotinylated antibodies on cell surface receptors, offering utility in fluorescence-based imaging and sensing.

18:0 mPEG3000 PE (ammonium) is a PEG lipid with functional end groups for synthesizing liposomes (LPs) and designing conjugated polymer nanoparticles. These liposomal nanoparticles (LNPs), featuring biotin modifications and carboxyl ends, facilitate further coupling with other biomolecules. The functionalized nanoparticles are useful for targeted labeling of specific cell proteins. Using streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, offering practicality for fluorescence-based imaging and sensing.

DMPE-PEG550 is a PEG lipid with functional end groups designed for the synthesis of liposomes (LPs) and the creation of conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) feature biotin modifications and carboxyl ends, allowing further coupling with other biomolecules. These functional nanoparticles are employed for targeted labeling of specific cell proteins. Using streptavidin as a linker, the biotinylated PEG lipid conjugate polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling applications in fluorescence-based imaging and sensing.

DMPE-PEG750 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) with biotin modification and carboxyl termini can couple with other biomolecules. These functional nanoparticles are useful for targeted labeling of specific cell proteins. Utilizing streptavidin as a linker, biotinylated PEG lipid conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling practical applications in fluorescence-based imaging and sensing.

DMPE-PEG1000 is a PEG lipid functional end group used for liposome (LPs) synthesis, instrumental in designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) can undergo further coupling with other biomolecules via biotin modification and carboxyl terminals. These functionalized nanoparticles are applicable for targeted labeling of specific cell proteins. Using streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling utility in fluorescence-based imaging and sensing.

DMPE-PEG5000 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Liposomal nanoparticles (LNPs), with biotin modification and a carboxyl terminus, can further couple with other biomolecules. Functionalized nanoparticles target specific cell proteins for labeling. Utilizing streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, offering practicality in fluorescence-based imaging and sensing.

18:1 PEG350 PE is a PEG lipid functional end group used in synthesizing liposomes (LPs) that is designed for the creation of conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) can couple with other biomolecules through biotin modifications and carboxyl terminals. Functionalized nanoparticles are employed for targeted labeling of specific cell proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, facilitating fluorescence-based imaging and sensing applications.

18:1 PEG550 PE is utilized as a PEG lipid functional end group for synthesizing liposomes (LPs) and designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs), featuring biotin modifications and carboxyl terminals, facilitate further coupling with other biomolecules. These functionalized nanoparticles are employed for targeted labeling of specific cellular proteins. Utilizing streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling fluorescence-based imaging and sensing applications.

18:1 PEG1000 PE is a PEG-lipid functional end group used in the synthesis of liposomes (LPs) and for designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) can be further coupled with other biomolecules through biotin modification and a carboxyl end. Functionalized nanoparticles are applicable for the targeted labeling of specific cell proteins. Using streptavidin as a linker, biotin-modified PEG-lipid conjugated polymer nanoparticles can bind with biotinylated antibodies on cell surface receptors, facilitating fluorescence-based imaging and sensing applications.

18:1 PEG3000 PE is a PEG lipid functional terminal group utilized in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Liposome nanoparticles (LNPs), modified with biotin and carboxy terminals, can couple with other biomolecules. Such functionalized nanoparticles are employed for targeted labeling of specific cell proteins. Using streptavidin as a linker, the biotinylated PEG lipid-conjugated polymer nanoparticles can bind with biotinylated antibodies on cell surface receptors, providing utility in fluorescence-based imaging and sensing.

18:1 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for designing conjugated polymer nanoparticles. These lipid nanoparticle complexes (LNPs), with biotin modification and carboxyl termini, can further couple with other biomolecules. The functionalized nanoparticles can target and label specific cell proteins. Using streptavidin as a linker, the biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling fluorescence-based imaging and sensing applications.

PLLA5000-PEG5000-BIO is a polylactic acid derivative that can form micelles in water. Additionally, PLLA5000-PEG5000-BIO is capable of binding tightly with avidin or streptavidin, making it suitable for protein labeling. This compound is also applicable in drug delivery research.

PLLA5000-PEG2000-BIO is a derivative of polylactic acid that can form micelles in water. Additionally, PLLA5000-PEG2000-BIO binds tightly with avidin or streptavidin, making it suitable for protein labeling. It is also applicable in drug delivery research.

PLLA5000-PEG1000-BIO is a polylactic acid derivative capable of forming micelles in water. Additionally, PLLA5000-PEG1000-BIO can tightly bind with avidin or streptavidin, making it suitable for protein labeling. This compound is also applicable in drug delivery research.

PLLA4000-PEG5000-BIO is a polylactic acid derivative known for forming micelles in water. In addition, PLLA4000-PEG5000-BIO has a strong binding affinity to avidin or streptavidin, making it suitable for protein labeling. This compound is also utilized in research related to drug delivery.